Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-04

Clinical Trial Update: Metformin as Added on Therapy in Patients With Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating adding metformin to standard therapy for ulcerative colitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Tanta University | Conditions: Inflammatory Bowel Diseases | Phase 2 | Status: RECRUITING